Aleph Farms, an Israeli cultivated meat startup, is facing funding challenges and has significantly reduced its valuation for an upcoming emergency fundraising round. The company aims to raise $25M but is expected to secure only $10M, based on a valuation of $80-100M, down 73% from its 2021 Series B round. This reflects broader market trends in the alternative protein sector, which has seen a sharp decline in investment since 2021 due to inflation, geopolitical issues, and meat industry pushback. Aleph Farms has adapted by cutting staff, focusing on cost reduction, and prioritizing profitability.
The firm emphasizes that its situation is not unique in the industry and views the current phase as a necessary adjustment period for long-term success in the cultivated meat sector.
Source: Aleph Farms: Lab-Grown Meat Pioneer Hits Funding Woes, Reflecting ‘Market Trends’